Navigation Links
Rhode Island Hospital fellow receives funding to support research in myocardial perfusion
Date:6/7/2011

(Providence, R.I.) Antonio Lassaletta, M.D., a fellow in cardiothoracic surgery research at Rhode Island Hospital, has been awarded a Research Fellowship from the Thoracic Surgery Foundation for Research and Education (TSFRE) to support his project, "Improving Myocardial Perfusion in a Diabetic Swine Model of Chronic Cardiac Ischemia." TSFRE awarded just two Research Fellowships in 2011; Lassaletta's fellowship is for two years.

TSFRE fellowships are designed to provide salary and/or direct experimental support for surgeons and surgical trainees who wish to acquire research skills. Particular emphasis is placed on evidence of supervisory interaction in the training environment. Lassaletta's research is being conducted under the guidance of Frank Sellke, M.D., chief of cardiothoracic surgery at Rhode Island Hospital and The Miriam Hospital. Sellke is nationally and internationally recognized for his clinical skills, commitment to excellence in patient care, and seminal and cutting-edge National Institutes of Health-supported cardiovascular research.

"Dr. Lassaletta has demonstrated a strong commitment to cardiothoracic care," said Sellke. "His work ethic and dedication to furthering patient care through research findings is commendable, and this fellowship is greatly deserved. The TSFRE is very selective in determining the recipients of these fellowships, and I am encouraged by their support of Dr. Lassaletta and his work."

Lassaletta's research measures the changes in blood supply to the heart in swine in order to investigate the effects of regenerative medicine. His goal is to determine if swine with Type I diabetes, suffering from reduced blood flow to the heart possibly brought on by coronary artery disease, will show improvement after the subjects receive a surgically implanted pump that encourages blood vessel growth in the heart, and that these improvements will be sustained with the addition of resveratrol. Resveratrol is a widely used FDA-unregulated supplement that has shown improved blood flow to the heart in humans.

The purpose of The Thoracic Surgery Foundation for Research and Education is to increase the knowledge base of cardiothoracic surgery and to enhance the knowledge of all thoracic surgeons so that ultimately patients may be better served. The TSFRE is committed to increasing resources by enlisting the participation of all thoracic surgeons and others who support its purpose. The Thoracic Surgery Foundation for Research and Education supports research and education initiatives to:

  • Increase knowledge and enhance treatment of patients with cardiothoracic diseases
  • Develop the skills of cardiothoracic surgeons as surgeon-scientists and health policy leaders
  • Strengthen society's understanding and trust in the profession


'/>"/>

Contact: Ellen Slingsby
eslingsby@lifespan.org
401-444-6421
Lifespan
Source:Eurekalert

Related medicine news :

1. Rhode Island Settlement Reflects Homeowner Liability for Serving Alcohol to Those Under 21, Says Providence Lawyer Mark Gemma
2. Rhode Island Hospital physician receives national award for research
3. Women & Infants launches Rhode Island Network for Pelvic Floor Disorders
4. Paper by Rhode Island Hospital physician selected among best of 2010 by JACR
5. Tishman Speyer Hosts Government, Union and Civic Leaders for Topping Out of Gotham Center Tower in Long Island City
6. Long Island Pediatric Group Announces Policy Changes That Will Help More New Yorkers
7. Long Island Press Investigates Big Tobacco's Lobby to Kill Indian Cigarette Trade
8. Long Island Children's Orthodontist Announces Office Improvements And New Staff Member
9. New Aspen Dental Office Opens in Grand Island, Nebraska
10. Relevant Public Relations President Barton Horowitz of Staten Island, N.Y., Chamber CEO Linda Baran Applauded By Congressman McMahon as SBA Honorees
11. Cyberknife of Long Island Destroys Prostate Cancer Non-Invasively Using Radiosurgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
Breaking Medicine Technology: